Clinical Trial Update: ONCOFID-P-B in the Intravescical Therapy of Patients With Non-muscle Invasive Cancer of the Bladder. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ONCOFID-P-B in intravesical therapy for non-muscle invasive bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-invasive Papillary Carcinoma of Bladder
• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• ONCOFID-P-B (paclitaxel-hyaluronic acid)

Snippet

Sponsor: Fidia Farmaceutici s.p.a. | Conditions: Non-Invasive Papillary Carcinoma of Bladder | Phase 2 | Status: COMPLETED